Literature DB >> 14556625

Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101).

Michael Strickler1, Barry M Goldstein, Kathleen Maxfield, Laura Shireman, Gyungyoun Kim, Donald S Matteson, Jeffrey P Jones.   

Abstract

Crystallographic and spectroscopic studies have been undertaken to characterize the binding behavior of the non-native substrate nicotine in the active site of the monooxygenase hemoprotein cytochrome P450cam. Despite the existence of a theoretical model that is consistent with the observed distribution of monooxygenation products, the crystal structure of the complex indicates that the primary binding mode of nicotine is unproductive. The structure is confirmed by spectral data that indicate direct coordination of substrate pyridine nitrogen with the heme iron. This would be the proper structure for evaluating binding affinity and inhibition. Reduction of the heme from Fe(III) to Fe(II) and introduction of carbon monoxide into crystals of the nicotine-P450cam complex, to simulate molecular oxygen binding, produces reorientation of the nicotine. This orientation is the appropriate one for predicting regioselectivity and the kinetic features of substrate oxidation. While it is not clear that such complicated behavior will be exhibited for other enzyme-substrate interactions, it is clear that a single crystal structure for a given substrate-enzyme interaction may not provide a good description of the binding mode responsible for product formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556625     DOI: 10.1021/bi034833o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Three clusters of conformational states in p450cam reveal a multistep pathway for closing of the substrate access channel.

Authors:  Young-Tae Lee; Edith C Glazer; Richard F Wilson; C David Stout; David B Goodin
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

2.  Two-dimensional NMR and all-atom molecular dynamics of cytochrome P450 CYP119 reveal hidden conformational substates.

Authors:  Jed N Lampe; Relly Brandman; Santhosh Sivaramakrishnan; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

3.  The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1.

Authors:  Jeffrey P Jones; Carolyn A Joswig-Jones; Michelle Hebner; Yuzhuo Chu; Dennis R Koop
Journal:  Chem Biol Interact       Date:  2011-05-10       Impact factor: 5.192

4.  The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.

Authors:  Joshua Pearson; Upendra P Dahal; Daniel Rock; Chi-Chi Peng; James O Schenk; Carolyn Joswig-Jones; Jeffrey P Jones
Journal:  Arch Biochem Biophys       Date:  2011-04-21       Impact factor: 4.013

5.  Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4.

Authors:  Jyothi C Talakad; Manish B Shah; Gregory S Walker; Cathie Xiang; James R Halpert; Deepak Dalvie
Journal:  Drug Metab Dispos       Date:  2010-12-14       Impact factor: 3.922

6.  Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.

Authors:  Josh T Pearson; John J Hill; Jennifer Swank; Nina Isoherranen; Kent L Kunze; William M Atkins
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

7.  Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.

Authors:  Chi-Chi Peng; Jonathan L Cape; Tom Rushmore; Gregory J Crouch; Jeffrey P Jones
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.